Experimental medication given to Ebola patient | WHAT REALLY HAPPENED

Experimental medication given to Ebola patient

The Ebola patient in a Dallas hospital is receiving an experimental antiviral drug called brincidofovir that was authorized on an emergency basis by the U.S. Food and Drug Administration, officials announced Monday afternoon.

The “investigational medication” was first administered to Thomas Eric Duncan, 42, at 2:14 p.m. Monday, said Candace White, a spokeswoman for Texas Health Presbyterian Hospital.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA